J&J
-
Recon
The robotic have-not: How J&J plans to woo hospitals, knee surgeons
By ARUNDHATI PARMAR – MedCity News, March 17, 2017 Johnson & Johnson and Verily Life Sciences (formerly Google Life Sciences) have…
Read More » -
Financial
Judge cuts $1B verdict against J&J in DePuy Pinnacle hip implant suit
January 4, 2017 – By BRAD PERRIELLO A federal judge in Texas again slashed a large jury verdict against Johnson & Johnson (NYSE:JNJ)…
Read More » -
Financial
Johnson & Johnson Could Become the First Company to Reach a $1 Trillion Valuation
Aug 22, 2016 – Sean Williams This year, we’ve witnessed all three major U.S. stock market indexes hit new all-time…
Read More » -
Top Stories
Intuitive Surgical sues J&J’s Ethicon for ‘legal gymnastics’ over sales rep’s non-compete
August 22, 2016 – By BRAD PERRIELLO Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon is using “intricate legal gymnastics” to sidestep California’s restrictions…
Read More » -
Recon
J&J to launch suite of orthopedics ‘solutions’ for outpatient joint replacement
By Varun Saxena Johnson’s & Johnson’s ($JNJ) DePuy is launching a comprehensive program to optimize outpatient joint replacement at U.S. ambulatory surgical…
Read More » -
Spine
SpineGuard, J&J, Medtronic & more — 20 key notes
By Anuja Vaidya Here are 20 key notes on orthopedic and spine device companies over the past week. The Washington,…
Read More » -
J&J’s Synthes Wins Round In Spat With Ex-Sales Rep
Johnson & Johnson’s Synthes subsidiary wins a round in its lawsuit against a former sales rep who jumped ship for…
Read More » -
Financial
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits By Jef Feeley & David Voreacos – Nov…
Read More » -
Financial
J&J’s Med Tech Buisness Falters Amid Weak Sales,
The calendar has finally caught up with Johnson & Johnson ($JNJ). Quarter after quarter, the healthcare giant watched its $21.3…
Read More » -
J&J Receives Private Equity Offers For Diagnostics Unit
(Reuters) – Some of the world’s largest private equity firms have made preliminary offers for Johnson & Johnson’s Ortho Clinical…
Read More » -
Hospitals
J&J’s $85K Chinese “Vertical Monopoly” Lesson
Johnson & Johnson (J&J) just learned an $85,000 lesson about China’s new monopoly law on behalf of all device companies.…
Read More » -
Recon
Biomet Metal Hip Lawsuit to Proceed
A lawsuit accusing Biomet of selling a faulty metal hip will proceed, after the Indiana device company failed to successfully…
Read More » -
J&J Said to Weigh $3 Billion Settlement of Its Hip Implant Cases
Johnson & Johnson, the world’s biggest seller of health-care products, has discussed paying more than $3 billion to settle lawsuits…
Read More »